Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Initiator Pharma logo — Empowering Lives Through Meaningful Therapies

Initiator Pharma

Empowering Lives Through Meaningful Therapies

Founded 2016 Denmark Denmark 9 employees Secondary Market Total: $20.00M Biotechnology, Health Care +1

General Information

Company Name Initiator Pharma
Founded Year 2016
Location Denmark Denmark
Founders / Decision Makers
Team member
Employees 9
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Secondary Market
Social

BounceWatch is an independent company data service, not affiliated with Initiator Pharma . To contact Initiator Pharma , visit initiatorpharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Initiator Pharma compare?

A PDF of Initiator Pharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Initiator Pharma soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Initiator Pharma

Initiator Pharma is a Denmark-based biotechnology startup focusing on developing cutting-edge drugs to address unmet medical needs within the central and peripheral nervous system. The company's clinical-stage pipeline includes three programs, with a focus on addressing erectile dysfunction of psychogenic and organic origin and a neuropathic pain program. Notably, their recent advancement in drug development has shown significant efficacy in preclinical models for Female Sexual Dysfunction (FSD). Since its founding in 2016, Initiator Pharma continues to make strides in developing innovative therapies. In April 2022, the company secured a kr20.00MSecondary Market investment with the participation of Adrigo Asset Management and Linc AB. Initiator Pharma's dedication to addressing significant medical challenges and their success in securing investment reflects the potential for meaningful impact and growth in the pharmaceutical industry. With a compelling slogan of "Empowering Lives Through Meaningful Therapies", Initiator Pharma is positioned as a promising player in the healthcare and pharmaceutical sectors.

Business keywords: pharmaceuticals, clinical-stage, biotech, drug development, neuroscience, erectile dysfunction, neuropathic pain, FSD, clinical trials, innovation, Denmark, stock exchange, quality of life, patient-centered

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Secondary Market kr20.00M 2
Adrigo Asset Management Linc AB
Adrigo Asset Management, Linc AB
13 Apr 2022

Initiator Pharma Alternatives & Competitors

View All Alternatives
Initiator Pharma vs
Cavion
Cavion

Empowering therapies for cancer and neurologic diseases through pioneering ion channel inhibition

Series A
Biotechnology, Health Care
Initiator Pharma vs
Athersys
Athersys United States

Committed to developing therapies to extend and enhance the quality of life.

Post-IPO Equity
37 employees
Biopharma, Biotechnology
Initiator Pharma vs
Denovo Biopharma
Denovo Biopharma United States

A Novel Biomarker Discovery Solution for Personalized Drug Development Denovo Biopharma is a priva...

Grant
29 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Initiator Pharma

Empowering Lives Through Meaningful Therapies
Initiator Pharma was founded in 2016.
Initiator Pharma is headquartered in Denmark.
Initiator Pharma operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on pharmaceuticals, clinical-stage, biotech and drug development.
Initiator Pharma has approximately 9 employees.
Initiator Pharma has completed 1 funding round, raising a total of $20.00M. The latest funding stage is Secondary Market.
Top alternatives and competitors to Initiator Pharma include Cavion, Athersys, Denovo Biopharma, Aegera Therapeutics Inc., Synerkine Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Initiator Pharma and Cavion are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Initiator Pharma , https://bouncewatch.com/company/initiator-pharma, updated 17 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout